Detalhe da pesquisa
1.
Pre-Treatment Mutational and Transcriptomic Landscape of Responding Metastatic Melanoma Patients to Anti-PD1 Immunotherapy.
Cancers (Basel)
; 12(7)2020 Jul 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32708981
2.
ALK Inhibitor Response in Melanomas Expressing EML4-ALK Fusions and Alternate ALK Isoforms.
Mol Cancer Ther
; 17(1): 222-231, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29054983
3.
Kinase gene fusions in defined subsets of melanoma.
Pigment Cell Melanoma Res
; 30(1): 53-62, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27864876
4.
Whole-exome sequencing identifies recurrent SF3B1 R625 mutation and comutation of NF1 and KIT in mucosal melanoma.
Melanoma Res
; 27(3): 189-199, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28296713
5.
IMPACT: a whole-exome sequencing analysis pipeline for integrating molecular profiles with actionable therapeutics in clinical samples.
J Am Med Inform Assoc
; 23(4): 721-30, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27026619
6.
Combining a GSI and BCL-2 inhibitor to overcome melanoma's resistance to current treatments.
Oncotarget
; 7(51): 84594-84607, 2016 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-27829238